The MHRA has launched a consultation on a new regulatory framework aimed at accelerating the development and approval of therapies for rare diseases. Published on 21st May 2026, the draft framework is designed to speed…
The post MHRA consults on draft regulatory framework for rare disease therapies appeared first on The Academy For Healthcare Science.